Wednesday, April 19, 2017

Jang Donghyeon SK president, field management Spurs



And [South Korea ohahreum financial newspaper reporter] SK Corporation Jang Donghyeon President welcomed two years integrated holding company launched a full-fledged site management.

Chapter June 18 (Reuters) - President was visiting the LSI (Life Science Inc.) SK Bio farm, the US subsidiary located in New Jersey, check the proprietary epilepsy drug (Cenobamate) clinical progress.

LSI was founded in 1993 and specialized personnel with local hires are responsible for the global clinical of the New Testament. EEG recognized the superior efficacy by the US FDA (Food and Drug Administration) increasing drug safety testing is underway in 17 countries as early as the end of the year led to the LSI enters the New Drug Application.

Chapter President discussed such as SK Bio farm Cho Jeongwoo representatives and local CCO (Chief Commercial Officer) of Borriello Sebastian (Sebastian Borriello), such as marketing executives and met epilepsy drug sales and global market entry plans through this visit.

Chapter president "has entered into our efforts poured in a long time, innovative drug development gradually paid off" in a meeting with US local member said that "let's continued ambition to run in to a vision realized that leap into a global pharmaceutical company." said.

SK Bio farm plans coming 22 to 28 to strengthen local marketing, participating as an official sponsor to be held at the Boston Society of nerve AAN (American Academy of Neurology) in the United States most prestigious.

The epilepsy drug that receives the last and the current clinical drug approved in the United States is the global marketing sales proceeds ∙ around the LSI. It will be the domestic pharmaceutical companies have long realized the goal hagetdaneun led from proprietary technology exports as opposed to the initial clinical marketing to achieve a 'drug sovereignty' in the world market.

SK㈜ said, "epilepsy drug commercialization is expected to be launched this year, the best performance since the SK Corporation, a global pharmaceutical company, will be the starting point of a jump," he said.

Chapter president after recent consolidation holding company launched the first visit SK Materials acquired company, Kyungpook 0 shares roamed the semiconductor specialty gases production sites.

SK Materials is pursuing a total investment of 150 billion expansion to 2,500 tons of NF3 (nitrogen trifluoride) manufacturing plant in North Gyeongsang Province 0 shares and large-scale expansion, such as the establishment of an etching gas plant, the world's largest this year and investment.

Meanwhile, Zhang said "Let's accelerate samgo the year following the global investment vision of specialized holding company in the first year of the 'Deep Change' (fundamental changes) Innovation in stable growth," the 20th through the message right the anniversary sent to members he urged.

He also emphasized, "Let's get out on the basis of the corporate culture of trust increases the competitiveness of existing businesses, laying the foundation for stable growth and unearthing new growth businesses continued to innovate as a professional investment holding company."

SK㈜ has a reputation that also fulfill such promises enhance shareholder value, as well as new business development promised a dividend payout ratio of 30% is also achieved early.

Industry insiders said, "At the time it launched the vision of SK Corporation hagetdaneun become a" global top level of professional investment holding company, and visualization has emerged as a role model for other national holding company ".



Daily Economic News Finance FNTIMES - commercial reprint, copy, distribute prohibited purposes under the Copyright Act
Copyright ⓒ Korea's Financial News & FNTIMES.com